regulatory policy

TORONTO, ON, April 16, 2026 PharmaTher Holdings Ltd. has announced its strong support for proposed U.S. regulatory reclassification of...

WASHINGTON, April 9, 2026 Vanda Pharmaceuticals Inc. has publicly called on the U.S. Food and Drug Administration (FDA) to...

HOUSTON, Texas — December 15, 2025 — Cannabis Bioscience International Holdings, Inc. (CBIH) issued a policy and science-focused update...